In the realm of pediatric cancer prediction, groundbreaking advancements are reshaping the future of treatment and care for young patients.A recent study highlights an innovative AI tool that significantly outperforms traditional methods in predicting the relapse risk associated with pediatric cancers, particularly gliomas.